Parkinson’s UK and the University of Sheffield have launched a groundbreaking ‘virtual biotech’ company to develop new treatments for Parkinson’s disease. To be called Keapstone ...

It was a big week for companies offering virtual nutrition services with Berry Street and Fay both receiving $50 million ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

The company’s disclosure falls under Item 7.01 – Regulation FD Disclosure in the Form 8-K filing. This section highlights the participation of Moleculin Biotech’s CEO in the virtual investor ...

The Company initiated its second lung cancer ... and upcoming milestones in a fireside chat at BTIG’s Virtual Biotechnology Conference 2024. The conversation with Kaveri Pohlman, PhD, Director ...